Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Better serving global partners and advancing healthcare innovation
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
Company raises the annual revenue guidance from mid-teens to high teens
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
